Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Marron

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry|October 23, 2010
Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic painMarc J C Scanio, Lei Shi, Irene Drizin, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2017
Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probesR Ian Storer, Andy Pike, Nigel A Swain, et al.
Plos One|April 7, 2016
Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic ReleaseAristos J Alexandrou, Adam R Brown, Mark L Chapman, et al.
JAAD International|February 16, 2026
Stress in dermatology patients: A multicenter observational study of 8295 outpatients and controls from 22 European clinicsFlora Balieva, Christina Schut, Csanád Szabó, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivativesMichael E Kort, Robert N Atkinson, James B Thomas, et al.
Bioorganic & Medicinal Chemistry|May 27, 2008
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic painIrene Drizin, Robert J Gregg, Marc J C Scanio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 5, 2026
Suicidal ideation in patients with skin conditions: A multicentre European studyF Sampogna, D Abeni, C Schut, et al.
The British Journal of Dermatology|January 18, 2022
Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countriesChristina Schut, Florence J Dalgard, Anthony Bewley, et al.
International Journal of Dermatology|November 11, 2024
Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in EuropeServando E Marron, Tamara Gracia-Cazaña, Francesca Sampogna, et al.
Acta Dermato-Venereologica|June 22, 2023
Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European CountriesSylvia Van Beugen, Christina Schut, Jörg Kupfer, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry|October 23, 2010
Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic painMarc J C Scanio, Lei Shi, Irene Drizin, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2017
Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probesR Ian Storer, Andy Pike, Nigel A Swain, et al.
Plos One|April 7, 2016
Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic ReleaseAristos J Alexandrou, Adam R Brown, Mark L Chapman, et al.
JAAD International|February 16, 2026
Stress in dermatology patients: A multicenter observational study of 8295 outpatients and controls from 22 European clinicsFlora Balieva, Christina Schut, Csanád Szabó, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivativesMichael E Kort, Robert N Atkinson, James B Thomas, et al.
Bioorganic & Medicinal Chemistry|May 27, 2008
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic painIrene Drizin, Robert J Gregg, Marc J C Scanio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 5, 2026
Suicidal ideation in patients with skin conditions: A multicentre European studyF Sampogna, D Abeni, C Schut, et al.
The British Journal of Dermatology|January 18, 2022
Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countriesChristina Schut, Florence J Dalgard, Anthony Bewley, et al.
International Journal of Dermatology|November 11, 2024
Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in EuropeServando E Marron, Tamara Gracia-Cazaña, Francesca Sampogna, et al.
Acta Dermato-Venereologica|June 22, 2023
Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European CountriesSylvia Van Beugen, Christina Schut, Jörg Kupfer, et al.
Pageof 10